
Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more
VJHemOnc Podcast
Introduction
Discussion on the latest developments in treating lower-risk MDS, including new therapies and the controversial Cintra Rev trial.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.